0,933  0,003  Chemoprotective
0,911  0,005  Apoptosis agonist
0,898  0,005  Antiinflammatory
0,885  0,007  Transcription factor NF kappa B inhibitor
0,851  0,004  Nitric oxide antagonist
0,839  0,006  Antineoplastic (breast cancer)
0,827  0,006  Antineoplastic (lung cancer)
0,796  0,005  Antineoplastic (ovarian cancer)
0,797  0,011  Caspase 9 stimulant
0,774  0,003  Hypoxia-inducible factor 1 alpha inhibitor
0,773  0,004  Hepatic disorders treatment
0,771  0,005  Prostate cancer treatment
0,768  0,008  Antileukemic
0,763  0,004  Antineoplastic (glioma)
0,731  0,009  Chemopreventive
0,714  0,004  Antineoplastic (glioblastoma multiforme)
0,709  0,004  Antineoplastic (multiple myeloma)
0,712  0,013  Antineoplastic (colorectal cancer)
0,710  0,013  Cyclophilin D inhibitor
0,710  0,013  Antidiabetic
0,706  0,013  Antineoplastic (colon cancer)
0,680  0,005  Cardioprotectant
0,669  0,008  Antineoplastic (melanoma)
0,660  0,004  Antineoplastic (endocrine cancer)
0,659  0,005  Antineoplastic (renal cancer)
0,662  0,009  Antineoplastic (cervical cancer)
0,659  0,007  Caspase 3 stimulant
0,663  0,011  Cholesterol antagonist
0,652  0,005  Apoptosis antagonist
0,653  0,007  AR expression inhibitor
0,646  0,004  Hepatoprotectant
0,644  0,009  Cytotoxic
0,626  0,010  Proliferative diseases treatment
0,605  0,006  Antineoplastic enhancer
0,606  0,007  Tumour necrosis factor alpha release inhibitor
0,606  0,009  Antineoplastic (brain cancer)
0,596  0,004  Phospholipase C inhibitor
0,596  0,010  Antineoplastic (non-small cell lung cancer)
0,595  0,010  Lipoprotein disorders treatment
0,591  0,009  Antipyretic
0,577  0,016  Immunosuppressant
0,556  0,003  DNA polymerase I inhibitor
0,579  0,029  TNF expression inhibitor
0,556  0,007  Antihypoxic
0,566  0,018  Bone diseases treatment
0,570  0,024  Antibacterial
0,550  0,008  Antihelmintic
0,546  0,017  Antineoplastic (pancreatic cancer)
0,526  0,008  ICAM1 expression inhibitor
0,530  0,017  Antifungal
0,525  0,014  Antiparasitic
0,508  0,005  Platelet adhesion inhibitor
0,502  0,005  Antiviral (Influenza)
0,499  0,012  Antihypertriglyceridemic
0,505  0,019  Antioxidant
0,485  0,005  Antiviral (Influenza A)
0,486  0,009  Antiviral (HIV)
0,504  0,028  Respiratory analeptic
0,486  0,014  Antineoplastic (lymphoma)
0,481  0,014  Hypolipemic
0,469  0,010  P-glycoprotein inhibitor
0,454  0,007  UGT2B7 substrate
0,453  0,008  Contraceptive
0,469  0,033  Immunostimulant
0,452  0,020  Hypoglycemic
0,453  0,027  NOS3 expression inhibitor
0,433  0,011  Abortion inducer
0,431  0,012  Antiviral (Herpes)
0,426  0,007  Protein kinase stimulant
0,447  0,029  Analeptic
0,444  0,027  Metabolic disease treatment
0,460  0,043  Atherosclerosis treatment
0,424  0,011  Sodium/bile acid cotransporter inhibitor
0,432  0,024  UGT2B4 substrate
0,410  0,003  Transcription factor NF kappa B stimulant
0,416  0,012  Antineoplastic (carcinoma)
0,428  0,026  Antidiabetic (type 2)
0,402  0,004  Antihelmintic (Nematodes)
0,395  0,004  Beta amyloid protein antagonist
0,393  0,005  Antifungal enhancer
0,402  0,015  UGT1A4 substrate
0,390  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,399  0,019  Antineoplastic (lymphocytic leukemia)
0,386  0,010  Lipocortins synthesis antagonist
0,397  0,023  Myocardial infarction treatment
0,372  0,005  Cholesterol synthesis inhibitor
0,421  0,058  Antiobesity
0,386  0,026  Antineoplastic (liver cancer)
0,392  0,034  NOS2 expression inhibitor
0,403  0,048  Antithrombotic
0,361  0,011  Protein-tyrosine phosphatase inhibitor
0,348  0,007  Antineoplastic antibiotic
0,369  0,031  Antidiabetic symptomatic
0,343  0,007  UGT2B9 substrate
0,362  0,029  Transcription factor STAT3 inhibitor
0,358  0,025  UDP-glucuronosyltransferase substrate
0,354  0,022  UGT1A1 substrate
0,340  0,015  Interferon gamma antagonist
0,328  0,015  Monophenol monooxygenase inhibitor
0,385  0,073  Antipruritic, allergic
0,338  0,027  Wound healing agent
0,340  0,032  Antiulcerative
0,323  0,018  Antiviral (Hepatitis)
0,340  0,035  Angiogenesis stimulant
0,320  0,017  Prostate disorders treatment
0,317  0,019  Antineoplastic (squamous cell carcinoma)
0,315  0,021  Prostatic (benign) hyperplasia treatment
0,296  0,010  Psychosexual dysfunction treatment
0,303  0,020  Hair growth stimulant
0,327  0,046  Antiprotozoal (Leishmania)
0,328  0,056  Antihypercholesterolemic
0,277  0,007  Contraceptive female
0,286  0,016  Antiviral (Hepatitis C)
0,348  0,079  CYP3A4 substrate
0,329  0,062  5 Hydroxytryptamine release stimulant
0,285  0,019  Liver fibrosis treatment
0,287  0,024  Antiacne
0,328  0,068  Immunomodulator
0,314  0,056  UGT1A9 substrate
0,266  0,017  Antiviral (Hepatitis B)
0,256  0,007  Microtubule formation inhibitor
0,251  0,005  Arachidonic acid antagonist
0,269  0,023  Lipid peroxidase inhibitor
0,269  0,029  Neurotrophic factor enhancer
0,242  0,007  Growth stimulant
0,299  0,067  Antiosteoporotic
0,241  0,013  Farnesoid X receptor antagonist
0,289  0,062  Transcription factor STAT inhibitor
0,228  0,002  Na+ K+ transporting ATPase inhibitor
0,230  0,005  Adenylate cyclase stimulant
0,229  0,004  Androgen agonist
0,252  0,030  UGT1A3 substrate
0,237  0,017  UGT2B10 substrate
0,294  0,079  Antipsoriatic
0,242  0,027  Skin whitener
0,219  0,008  Aromatase inhibitor
0,214  0,012  Antiinfertility, female
0,261  0,063  Vasodilator
0,212  0,018  Expectorant
0,206  0,013  Androgen antagonist
0,217  0,032  Interleukin 6 antagonist
0,256  0,073  Vascular (periferal) disease treatment
0,189  0,005  Paget's disease treatment
0,187  0,005  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,203  0,034  Insulin secretagoues
0,176  0,008  Anabolic
0,187  0,020  Choleretic
0,242  0,077  Cardiovascular analeptic
0,169  0,005  Glycine receptor antagonist
0,204  0,040  Acute respiratory distress syndrome (ARDS) treatment
0,171  0,008  UGT2B11 substrate
0,212  0,053  Antipruritic, non-allergic
0,197  0,044  UGT2B15 substrate
0,212  0,063  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,152  0,003  Antitreponemal
0,190  0,041  Antidiarrheal
0,143  0,000  Telomerase stimulant
0,157  0,015  Contraceptive male
0,222  0,082  Cytostatic
0,254  0,114  Interleukin 2 agonist
0,164  0,026  Alcohol dehydrogenase substrate
0,140  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,141  0,006  Acetyl-CoA transferase inhibitor
0,169  0,034  Antihemorrhagic
0,201  0,069  Carcinogenic
0,245  0,115  CTGF expression inhibitor
0,132  0,008  Anticholelithogenic
0,151  0,028  AMP-activated protein kinase stimulant
0,146  0,032  HDL-cholesterol increasing
0,194  0,081  Sensitization
0,225  0,112  Gastrin inhibitor
0,216  0,104  Chronic obstructive pulmonary disease treatment
0,116  0,005  RNA-directed RNA polymerase stimulant
0,115  0,004  Acetyl-CoA transferase 2 inhibitor
0,130  0,022  Lanosterol 14 alpha demethylase inhibitor
0,185  0,080  Sedative
0,108  0,006  Heme oxygenase stimulant
0,138  0,036  Anticataract
0,165  0,064  Melanin inhibitor
0,137  0,036  UGT2B1 substrate
0,100  0,007  Diacylglycerol O-acyltransferase inhibitor
0,094  0,003  Tubulin agonist
0,181  0,096  Antimitotic
0,191  0,106  Antiamyloidogenic
0,117  0,032  SULT1E1 substrate
0,113  0,029  Antibiotic
0,090  0,008  Lipocortins synthesis agonist
0,115  0,034  ABCA1 expression enhancer
0,192  0,112  RNA-directed DNA polymerase inhibitor
0,124  0,045  Protease inhibitor
0,143  0,066  Pregnane X receptor agonist
0,135  0,062  Cyclooxygenase 3 inhibitor
0,183  0,110  UGT1A6 substrate
0,075  0,005  Microtubule stabilization
0,089  0,020  Estrogen agonist
0,106  0,037  Bile acid receptor antagonist
0,085  0,019  SULT2A1 substrate
0,239  0,175  Antiprotozoal
0,172  0,109  Teratogen
0,157  0,097  Toxic, respiratory center
0,161  0,103  Antirickettsial
0,071  0,014  5-Alpha-reductase inhibitor
0,062  0,007  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,173  0,121  Free radical scavenger
0,137  0,085  Ca2+-transporting ATPase inhibitor
0,076  0,025  Andropause treatment
0,057  0,006  Estrone sulfatase inhibitor
0,074  0,024  Postmenopausal disorders treatment
0,057  0,008  Glucose-6-phosphate dehydrogenase inhibitor
0,064  0,019  Anesthetic inhalation
0,068  0,024  Postcoital contraceptive
0,069  0,025  Protein 50S ribosomal subunit inhibitor
0,055  0,012  Hypogonadism treatment
0,057  0,014  Parathyroid hormone antagonist
0,139  0,097  Growth hormone agonist
0,102  0,060  Carbonic anhydrase III inhibitor
0,040  0,003  Vitamin D receptor agonist
0,042  0,004  Hedgehog signaling activator
0,107  0,070  Antiviral (Coronavirus)
0,107  0,070  Antiviral (SARS coronavirus)
0,055  0,019  Liver X receptor agonist
0,061  0,024  Phosphorylase inhibitor
0,053  0,019  Estrogen receptor beta agonist
0,047  0,013  Cholesterol absorption inhibitor
0,045  0,013  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,116  0,086  Anesthetic
0,089  0,060  Actinic keratosis treatment
0,046  0,017  Farnesoid X receptor agonist
0,083  0,055  Antiviral (Dengue virus)
0,060  0,032  Pregnane X receptor antagonist
0,155  0,127  Insulin sensitizer
0,037  0,015  Cholesterol ester transfer protein antagonist
0,027  0,008  Corticosteroid-like
0,039  0,022  Antibiotic Aminoglycoside-like
0,141  0,124  LDLR expression enhancer
0,071  0,054  Glycine receptor agonist
0,141  0,125  Embryotoxic
0,138  0,123  ATPase inhibitor
0,037  0,022  Estrogen receptor alpha agonist
0,036  0,021  HMG CoA reductase inhibitor
0,040  0,026  Retinoic acid alpha receptor agonist
0,107  0,097  Retinoprotector
0,059  0,049  Antimycoplasmal
0,137  0,129  Anesthetic general
0,043  0,038  Potassium channel Kv1.3 blocker
0,013  0,009  Glucocorticoid agonist
0,057  0,054  Nitric oxide donor
0,016  0,013  Progesterone agonist
0,134  0,131  Diabetic nephropathy treatment
0,134  0,131  Antineoplastic (gastric cancer)
0,028  0,025  Glucocorticoid antagonist
0,103  0,101  Constipation treatment
0,171  0,171  CYP2C19 substrate

